IgA Nephropathy and IgA Vasculitis / HSP: New terminology and pathophysiology, old treatments?
Treatment challenges in IgA Nephropathy and Henoch Schoenlein Purpura nephritis/ IgA vasculitis
Sunday, April 24, 2022
1:40 PM – 2:00 PM US MT
Location: Convention Center: 708/710/712
Speaker(s)
Michelle Rheault, MD
Associate Professor University of Minnesota Masonic Children's Hospital Minneapolis, Minnesota, United States
Participants should be aware of the following financial/non-financial relationships:
Michelle Rheault, MD: ● Chinook (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Reata (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Sanofi (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Travere (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Visterra (Ended In the Past 24 Months) (Products/Services: Consultant).
